Supplier WHO GMP non-compliance during WHO inspection – evidence pack for WHO audits



Published on 28/01/2026

Addressing WHO GMP Non-Compliance during Inspections: A Practical Guide

Pharmaceutical manufacturers face increasing scrutiny regarding compliance with Good Manufacturing Practices (GMP), especially during inspections by the World Health Organization (WHO). Non-compliance can result in significant repercussions, including delayed product approvals and market access issues. This article provides an actionable playbook to effectively address WHO GMP non-compliance detected during inspections, focusing on immediate actions, comprehensive investigations, and rigorous controls.

By following this guide, professionals in production, quality control, quality assurance, engineering, and regulatory affairs will understand how to identify signs of non-compliance, investigate root causes, implement corrective actions, and prepare for inspections with confidence. The following sections break down the approach into manageable tasks to support your compliance strategy.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms that indicate potential WHO GMP non-compliance is critical. These signals may occur in different areas of the manufacturing process and can include:

  • Inconsistent product quality: Variations in critical quality attributes (CQAs) of the product.
  • Deviations from procedures: Unapproved changes
to standard operating procedures (SOPs) or manufacturing protocols.
  • Frequent equipment malfunctions: Low equipment reliability leading to increased downtime.
  • Missing documentation: Incomplete batch records, failure to document critical processes properly.
  • Inadequate training: Staff lacking necessary training leading to human errors.
  • Increased deviations or complaints: A spike in product complaints or non-conformance reports.
  • Likely Causes

    Understanding the root causes of GMP non-compliance is essential for creating effective corrective actions. These causes can generally be categorized into six areas: Materials, Method, Machine, Man, Measurement, and Environment.

    Category Likely Causes
    Materials Substandard materials, lack of supplier qualification, contamination.
    Method Improper methodologies, deviations from validated processes, lack of SOP adherence.
    Machine Equipment malfunctions, poor maintenance, lack of calibration.
    Man Inadequate training, lack of awareness of GMP regulations, insufficient staffing.
    Measurement Faulty measurement tools, poor monitoring practices, inadequate sampling.
    Environment Poor cleanroom practices, inadequate environmental controls, contamination risks.

    Immediate Containment Actions (First 60 Minutes)

    Upon detecting potential WHO GMP non-compliance, immediate containment is vital to prevent further impact. Actions should include:

    • Cease affected operations: Halt the production or testing processes that are impacted.
    • Inform relevant stakeholders: Notify the quality assurance team and management immediately.
    • Secure affected products: Isolate impacted batches and ensure they are not shipped.
    • Document observations: Record the initial findings, observations, and context surrounding the issue for later investigation.
    • Initiate an initial assessment: Gather data on production equipment, materials used, and personnel involved.

    Investigation Workflow

    Effective investigations require systematic approaches to collect and analyze relevant data. The workflow should implement the following steps:

    1. Data Collection:
      • Gather batch records, logs, equipment maintenance records, and training documentation.
      • Interview personnel involved in the production process.
    2. Data Analysis:
      • Compile and analyze data to identify trends or anomalies that correlate with the non-compliance issue.
      • Use metrics (e.g., yield, defect rates) for deeper insight into the manufacturing process.
    3. Contextual Understanding:
      • Examine external factors (such as supplier performance, raw material quality) that may have contributed to the issue.
      • Evaluate internal environmental control measures.
    4. Documentation: Properly document each step taken during the investigation in a structured manner to ensure traceability.

    Root Cause Tools

    Determining the root cause of identified non-compliance issues is essential in crafting an effective CAPA strategy. Various tools can be employed based on the specifics of the non-compliance:

    • 5-Why Analysis: A straightforward technique to explore the cause-and-effect relationships underlying a problem by asking “why” repeatedly, typically five times.
    • Fishbone Diagram (Ishikawa): Useful for categorizing potential causes into structured categories to identify all possible contributors to the issue.
    • Fault Tree Analysis: A more complex tool that uses logic to determine the various combinations of failures that could lead to non-compliance.

    Choosing the right tool depends on the complexity of the problem and the resources available. For more straightforward issues, 5-Why may suffice, while more complex cases may benefit from a Fishbone or Fault Tree analysis.

    CAPA Strategy

    The Corrective and Preventive Action (CAPA) strategy constitutes three main components:

    1. Correction: Immediate actions taken to resolve the identified non-compliance. This may include reprocessing, re-testing, or disposing of affected materials.
    2. Corrective Action: Actions implemented to address the root causes identified during the investigation, which may require procedural updates, training sessions, or equipment recalibration.
    3. Preventive Action: Long-term strategies aimed at preventing recurrence, such as ongoing training programs, regular audits, and supplier assessments.

    Documenting each step in the CAPA process is critical for regulatory compliance and to demonstrate accountability during inspections.

    Control Strategy & Monitoring

    Establishing a robust control strategy enhances QMS and mitigates risks of non-compliance. Key elements include:

    • Statistical Process Control (SPC): Implement SPC to monitor critical parameters of the manufacturing process for variability that could affect product quality.
    • Regular Sampling: Set up a schedule for routine sampling of raw materials, in-process samples, and final products.
    • Alarm Systems: Utilize alarm systems for critical process deviations to alert staff immediately.
    • Verification Processes: Regular audits of processes, equipment, and personnel to verify compliance with SOPs and established guidelines.

    Validation / Re-qualification / Change Control Impact

    After addressing GMP non-compliance, it’s essential to evaluate whether any validation, re-qualification, or change control measures are required:

    • Validation: Any change to processes, equipment, or materials necessitates a re-evaluation of validation protocols to ensure continuing compliance.
    • Re-qualification: If equipment was found non-compliant, formal re-qualification is mandatory before resuming use.
    • Change Control: Document any changes made as part of the CAPA strategy. Engage with the change control process to ensure proper assessment and approval before implementation.

    Inspection Readiness: What Evidence to Show

    Preparation for inspections requires meticulous documentation and a clear communication strategy. Key records and evidence include:

    Related Reads

    • Batch Records: Ensure complete and accurate batch production and control records are available for review.
    • Deviation Reports: Provide detailed accounts of any deviations encountered and actions taken in response.
    • Training Records: Maintain records demonstrating personnel qualifications and training related to GMP compliance.
    • CAPA Documentation: Document and organize CAPA actions, highlighting how each addressed specific compliance issues.

    Ready access to this information during an inspection fosters transparency and demonstrates a commitment to GMP compliance.

    FAQs

    What are the common signs of WHO GMP non-compliance?

    Common signs include inconsistencies in product quality, deviations from procedures, equipment malfunctions, and incomplete documentation.

    Why is immediate containment necessary?

    Immediate containment prevents further impact on product quality and ensures that the issue does not affect additional batches or operations.

    How can I effectively collect data during an investigation?

    Collect batch records, logs, interview relevant personnel, and examine production environments to gather comprehensive data.

    What CAPA strategies should be prioritized?

    Focus on correction of immediate issues, corrective actions addressing root causes, and preventive actions ensuring non-recurrence.

    When should I consider re-validation of processes?

    Re-validation is necessary when significant changes are made to processes, equipment, or materials that affect product quality.

    How often should equipment be calibrated?

    Calibration frequency should comply with manufacturer guidelines and regulatory standards, typically involving annual assessments or more frequently for critical equipment.

    What documentation is critical for inspection readiness?

    Batch records, deviation reports, training certifications, and complete CAPA documentation are essential for demonstrating compliance during inspections.

    What role does training play in preventing GMP non-compliance?

    Training equips personnel with the necessary knowledge and skills to follow GMP guidelines and execute procedures correctly, which mitigates risks of human errors.

    Can human errors lead to non-compliance?

    Yes, human errors, often resulting from inadequate training or stress, are significant contributors to GMP non-compliance and should be addressed through ongoing personnel development.

    Why is SPC important in monitoring compliance?

    Statistical Process Control helps identify process variability early, thereby enabling quick corrective actions and maintaining compliance.

    How can supplier qualifications impact GMP compliance?

    Unqualified suppliers may deliver substandard materials that compromise product quality, making supplier audits and qualifications critical components of GMP compliance.

    What should I do if a supplier fails a qualification audit?

    Immediately evaluate the scope of the failure, communicate with the supplier, implement corrective actions, and consider alternative suppliers if necessary.

    Pharma Tip:  Supplier WHO GMP non-compliance during API sourcing – WHO inspector expectations explained